Intellia Therapeutics Inc buy BMO Capital Markets
Start price
10.05.24
/
50%
€22.72
Target price
10.05.25
€64.98
Performance (%)
-10.83%
Price
13:22
€20.26
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -10.83%. This prediction currently runs until 10.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intellia Therapeutics Inc | -16.458% |
iShares Core DAX® | -0.683% |
iShares Nasdaq 100 | 0.335% |
iShares Nikkei 225® | -1.486% |
iShares S&P 500 | -0.523% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target raised by analysts at BMO Capital Markets from $62.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€58.01
10.11.24
10.11.24
-10.27%
13:22
13:22
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.37
13.03.23
13.03.23
-
13.03.24
13.03.24
-27.88%
14.03.24
14.03.24